2 days ago · WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's disease have taken an hit.. A new study found that a drug in the same class called exenatide, marketed as Byetta, had no effect on slowing the disease or easing its symtoms.. The trial, published Feb. 4 in The Lancet, followed 194 people with Parkinson's disease for 96 weeks.

2 days ago · WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's disease have taken an hit.

2 days ago · A rigorous study that randomly assigned Parkinson’s patients to take exenatide, a relative of Ozempic, showed absolutely no benefit or slowing of the course of the degenerative disease after 96 ...

1 day ago · A drug for treating diabetes similar to popular weight-loss medicines such as Ozempic did not show any benefits for people with Parkinson’s disease, according to a new study. Researchers ...

Jan 21, 2025 · Emerging research suggests a potential link between the brain's decreased sensitivity to the hormone insulin and the progression of Parkinson's. This observation has prompted researchers to investigate whether anti-diabetic medications that help manage insulin levels could potentially slow the progression of Parkinson's.

Apr 3, 2024 · Now, nearly 200 years since Parkinson expressed his hope, and after four decades of unsuccessful clinical trials, a group of French researchers reports the first glimmer of success — a modest...

May 6, 2024 · The researchers found that an older diabetes drug, which is a precursor to Ozempic, may have a protective effect on the nervous system in people living with early-stage Parkinson's disease. This recent study builds on previous research that was conducted in mice.

Jul 1, 2024 · In this latest study, the drug, manufactured by Sanofi, helped slow the progression of motor disability after 12 months in people in an early stage of Parkinson’s disease.

Apr 4, 2024 · A new, small study suggests it could: Over the course of a year, a group of French researchers followed 156 people with early Parkinson’s who were randomly given lixisenatide, a GLP-1 receptor...

THURSDAY, April 4, 2024 -- Could a medication similar to the blockbuster weight-loss drugs Ozempic and Wegovy slow the ravages of Parkinson's disease? A new, small study suggests it could: Over the course of a year, a group of French researchers followed 156 people with early Parkinson’s who were randomly given lixisenatide , a GLP-1 receptor ...